Vanda Pharmaceuticals put the VQW-765 development program on hold while conducting a review of the complete VQW-765 trial dataset

From the articleVanda says anxiety drug failed main goal of late-stage study, puts program on hold | ReutersAlso in Vanda’s social anxiety drug flunks Phase 3 trial in female patients